Access
This article is part of Nature's premium content.
Please note this is News in Brief, and so will be a short article.
Published online 18 February 2009 | Nature | doi:10.1038/457949e
GSK backs patent pool for neglected diseases
To read this story in full you will need to login or make a payment (see right).
Please note this is News in Brief, and so will be a short article.
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
I would like to commend GlaxoSmithKline and Mr. Witty very highly for taking theses steps forward in responsibility -- each of them. Best hopes that others indeed take up the invitation, and so there can be a 'segmentation' which makes sense for everyone here. Best regards, Roald Laurenson